Diving Into Deciphera Pharmaceuticals [Seeking Alpha]
Deciphera Pharmaceuticals, Inc. (DCPH)
Last deciphera pharmaceuticals, inc. earnings: 3/9 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
deciphera.com/investor-relations
Company Research
Source: Seeking Alpha
Vimseltinib is expected to make significant progress in the TGCT indication, as the only approved therapy is under a Risk Evaluation and Mitigation Strategy protocol. Deciphera's switch-control kinase inhibitor platform aims to produce compounds that target specific regions of kinases, resulting in higher activity and lower toxicity compared to current kinase inhibitors. An investment analysis around Deciphera Pharmaceuticals follows in the paragraphs below. Shares of kinase biology concern Deciphera Pharmaceuticals, Inc. ( NASDAQ: DCPH have rallied 40% since late October, after positive pivotal trial data from vimseltinib in the treatment of TGCT or tenosynovial giant cell tumor. With the only Recommended For You Recommended For You About DCPH Stock Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
DCPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DCPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DCPH alerts
High impacting Deciphera Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
DCPH
News
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, DPSI, UNITGlobeNewswire
- Lifshitz Law PLLC Announces Investigations of DCPH, SLCA, HCP, and HTLFAccesswire
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCBC, DCPH, HTLF, TBNKPR Newswire
- Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More [Yahoo! Finance]Yahoo! Finance
- DECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Deciphera Pharmaceuticals, Inc. - DCPHBusiness Wire
DCPH
Earnings
- 2/6/24 - Beat
DCPH
Sec Filings
- 5/6/24 - Form SC
- 4/30/24 - Form SC
- 4/30/24 - Form SC14D9C
- DCPH's page on the SEC website